Past performance
About Advanced Enzyme Technologies Ltd Advanced Enzyme Technologies Limited (AETL) is India's largest enzyme company, leading globally in enzyme manufacturing and sales. Established in 1989 as Advanced Biochemicals Private Limited, the company underwent several transformations, eventually becoming Advanced Enzyme Technologies Limited in 2005. AETL expanded its international presence by acquiring Cal-India Foods International and Advanced Supplementary Technologies Corporation in 2011 and 2012, respectively. Its IPO in 2016 was highly successful, with shares listed on NSE and BSE.
The company has pursued a series of strategic acquisitions to bolster its market position, including JC Biotech Private Limited, AEM, evoxx technologies GmbH, and SciTech Specialities Private Limited. In 2023, AETL launched Wellfa, a B2C brand, and introduced innovative enzyme products. Recent acquisitions increased its stake in JC Biotech to 95.72%. These moves underscore AETL's commitment to growth and innovation in the enzyme industry, making it a key player for traders to watch.
Performance overview